Compare BLLN & HRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | HRI |
|---|---|---|
| Founded | 2016 | 1965 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Misc Corporate Leasing Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.3B |
| IPO Year | N/A | 2006 |
| Metric | BLLN | HRI |
|---|---|---|
| Price | $96.06 | $136.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $126.71 | ★ $162.33 |
| AVG Volume (30 Days) | ★ 771.8K | 410.4K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,376,000,000.00 |
| Revenue This Year | $46.29 | $10.12 |
| Revenue Next Year | $30.14 | $6.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.65 |
| 52 Week Low | $61.96 | $88.45 |
| 52 Week High | $138.70 | $188.35 |
| Indicator | BLLN | HRI |
|---|---|---|
| Relative Strength Index (RSI) | 55.60 | 54.25 |
| Support Level | $79.07 | $128.12 |
| Resistance Level | $97.36 | $142.04 |
| Average True Range (ATR) | 7.92 | 6.75 |
| MACD | 0.95 | -0.58 |
| Stochastic Oscillator | 58.11 | 48.69 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Herc Holdings is an equipment rental company that was spun out of Hertz Global in 2016. It is currently the third-largest player in North America, after United Rentals and Sunbelt Rentals, with an approximate 6% market share pro forma for its 2025 acquisition of H&E Equipment Services. It serves a similar mix of companies to its peers (industrial, commercial, and residential construction) from its 450 locations targeting the top 100 metropolitan markets in the US. Herc's rental fleet of approximately $7 billion is also similar in composition to its peer group in terms of equipment offered. The company is also pursuing diversification by bundling and increasing specialty solutions for its customer base. Herc's portfolio skews toward local customers versus national accounts (60%/40%).